# EryDex Pharmacokinetics in Healthy Volunteers

> **NCT01925859** · PHASE1 · COMPLETED · sponsor: **Quince Therapeutics S.p.A.** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** EryDex (dexamethasone sodium phosphate encapsulated erythrocytes)

## Key facts

- **NCT ID:** NCT01925859
- **Lead sponsor:** Quince Therapeutics S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01925859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01925859, "EryDex Pharmacokinetics in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01925859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*